A new Risk Evaluation and Mitigation Strategy (REMS) will aim to reduce the misuse of long-acting opioids

June 2011

A new Risk Evaluation and Mitigation Strategy (REMS) will aim to reduce the misuse of long-acting opioids.

Unintentional deaths due to opioids have quadrupled in 8 years...and treatment for opioid abuse has increased five-fold in 10 years.

Now FDA will require manufacturers to come up with a REMS plan by mid-August...with the changes rolled out by early 2012.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote